0001843252-21-000002.txt : 20211130 0001843252-21-000002.hdr.sgml : 20211130 20211130134022 ACCESSION NUMBER: 0001843252-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211130 DATE AS OF CHANGE: 20211130 EFFECTIVENESS DATE: 20211130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vita Therapeutics, Inc. CENTRAL INDEX KEY: 0001843252 IRS NUMBER: 832995717 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-422876 FILM NUMBER: 211459074 BUSINESS ADDRESS: STREET 1: 1812 ASHLAND AVENUE STREET 2: UNIT 110 CITY: BALTIMORE STATE: MD ZIP: 21205 BUSINESS PHONE: 609-339-5126 MAIL ADDRESS: STREET 1: 1812 ASHLAND AVENUE STREET 2: UNIT 110 CITY: BALTIMORE STATE: MD ZIP: 21205 D 1 primary_doc.xml X0708 D LIVE 0001843252 Vita Therapeutics, Inc. 1812 ASHLAND AVENUE UNIT 110 BALTIMORE MD MARYLAND 21205 609-339-5126 DELAWARE None None Corporation true 2018 Douglas Falk 1812 Ashland Avenue Unit 110 Baltimore MD MARYLAND 21205 Executive Officer Director Faizzan Ahmad 1812 Ashland Avenue Unit 110 Baltimore MD MARYLAND 21205 Director Vlad Coric 1812 Ashland Avenue Unit 110 Baltimore MD MARYLAND 21205 Director James Peyer 1812 Ashland Avenue Unit 110 Baltimore MD MARYLAND 21205 Director Pat LaVecchia 1812 Ashland Avenue Unit 110 Baltimore MD MARYLAND 21205 Director Biotechnology Decline to Disclose 06b false 2021-06-21 false true false 0 11999992 11999992 0 false 15 0 0 0 false Vita Therapeutics, Inc. /s/ Douglas Falk Douglas Falk CEO 2021-11-30